Your Best Source For Top Stock Picks, Stock Rankings, Stock Screening, Swing Trading, Hourly Stock Alerts, Market Strategies, Portfolio Tools and More...
2012-02-03: We took **** profits in ****. You may want to try for a larger move if you hold this position....Read more
HI-EPSRSTM Stock Screener Database Updated Daily. Top Picks Updated by 8:00a on Weekdays or on Weekends.
Tip: Analysis of our Past Winners* indicates that the following factors had the most correlation with stock price performance: • Accumulation Distribution • Institutional Sponsorship • Liquidity% • %Above 40-wk MA • Industry Group Action • Sales Growth% • GSA Rank • %Below 52-wk High
Search Wizard Use Our 3-Step Process to Quickly Identify Top Ranked Timely Stocks.
Step 1 - "Must Have" Factors GSA Rank > 70, Acc. Dist. > 1, Avg.Vol > 10,000, Liquidity > 0.5%, Institutional Ownership < 70%
End Wizard When Done
Spectrum Pharmaceuticals to Present at the J. P. Morgan Healthcare Conference Wed, 04 Jan 2012 12:00:00 GMT [Business Wire] - Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the 30th Annual J.
Akorn Inc (AKRX) $10.91 -0.17 (-1.6%) on 70% avg vol. Relative Strength Rank Today: 14 Range Today: 3.4% 1/6/2012 4:00pm
2012-01-28: Adding Acorn Inc (AKRX) to the watch list for a buy above it's $11.37 pivot. AKRX exceeds all our sales and earnings growth criteria (accelerating triple digit EPS growth, accelerating double digit sales growth), is undervalued on a forward PE basis, sports a healthy ROE of 19.7%, and shows good accumulation in a tight 4-wk basing pattern, providing a maximum trade risk of -4.6% if purchased at the pivot point.
Vital Signs
GSA Rank
Earnings Consistency 0.2/1.0
Sales Consistency 0.7/1.0
Looks Like A Winner? 3/10
Investor Sentiment 3.8/5.0 (8)
Entry Risk Above Support 1%
Group Action Today -0.79%
"Must Have"/Timing Factors
GSA 88.40
Acc Dist 1.25
Disc -7.23%
Avg Vol 1,217,200
Liquidity 1.36%
Below High 7.31%
Group Action 39
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS 250% N/A%
EPS Growth 107%
Sls Growth 31%
Proj Growth 28%
Anal. Rank 4.69
Shares 94.8M
Instit 60%
3-Month Trends of Key Indicators:
Looks Like a Winner?
AKRX looks better than most Top Picks Winners* in 3 out of 10 key factors.
Altisource Portfolio Solutions SA (ASPS) $50.49 +0.16 (0.3%) on 95% avg vol. Relative Strength Rank Today: 75 Range Today: 1.08% 1/6/2012 4:00pm 2012/01/03-PastPick-50.65 Target Price 25-30% from $50.65: $63.31-$65.85. No Profits Before 2012/01/31.
2012-01-15: For Tuesday, we have two names on our watch list - ASPS above $50.77 and VPHM above $29.49. We continue to be incremental in building the portfolio - no more than 5-6% in any one position.
Vital Signs
GSA Rank
Earnings Consistency 0.7/1.0
Sales Consistency 1.0/1.0
Looks Like A Winner? 6/10
Investor Sentiment 2.5/5.0 (4)
Entry Risk Above Support 5%
Group Action Today -0.17%
"Must Have"/Timing Factors
GSA 87.70
Acc Dist 2.64
Disc -34.44%
Avg Vol 117,800
Liquidity 0.54%
Below High 1.62%
Group Action 16
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS 82% -17%
EPS Growth 79%
Sls Growth 45%
Proj Growth 20%
Anal. Rank 5.00
Shares 23.9M
Instit 0%
3-Month Trends of Key Indicators:
Looks Like a Winner?
ASPS looks better than most Top Picks Winners* in 6 out of 10 key factors.
KILL MetLife Reverse, Lenders One® Renew Partnership Wed, 16 Nov 2011 00:31:00 GMT [Business Wire] - Lenders One Mortgage Cooperative requests that their press release, NewsItemId: 20111115006700, entitled “MetLife Reverse, Lenders One® Renew Partnership,†which was issued by them without proper authorization from MetLife Inc., be killed.
Salix Pharmaceuticals to Present at J.P. Morgan Healthcare Conference Wed, 04 Jan 2012 15:00:00 GMT [Business Wire] - Salix Pharmaceuticals, Ltd. today announced that the Company will present at The 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2012 at 4:30 p.m.
Approach Resources Inc. to Participate in Upcoming Conference Tue, 03 Jan 2012 22:30:00 GMT [Business Wire] - Approach Resources Inc. today announced that the Company will participate in the BMO Capital Markets 9th Annual Unconventional Resource Conference in New York, New York, on Tuesday, January 10, 2012, at 1:45 PM ET.
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that the particular criteria did not meet our minimum requirements, e.g., a low GSA Rank would be shown in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 2.28 (median winner: 1.58)
Instit. Ownership: 65% (median winner: 47%)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.